_.png)
Aging Reimagined
Caren Pharma is pioneering novel hormone-based
approaches to combat age-related diseases
Problem
Hormones have the potential to revolutionize aging, but are largely avoided due to perceived risks
Problem Restated
Deeper dives into the literature shows that the true culprit behind these risks is not being addressed
Solution
Our patented combinations unlock hormones' therapeutic benefits while preventing risks
Caren Pharma is a preclinical stage bio-pharma with a
platform of therapeutics to combat age-related diseases
Our Story
Ed Friedman, PhD (U of Chicago) has been a Theoretical Biologist for nearly 30 years. By independently analyzing thousands of publications, Ed became a world expert on hormone receptors. He wrote a book, spoke at several conferences, and published 14 letters and articles (here).
In 2019, his son, David Friedman, was working in Finance when when he began exploring Ed’s scientific model. David recognized that this science could help millions of people. Caren Pharma was formed to make that a reality.
